Navigation Links
EntreMed Reports First Quarter 2012 Financial Results
Date:5/15/2012

ROCKVILLE, Md., May 15, 2012 /PRNewswire/ -- EntreMed, Inc. (NASDAQ: ENMD), a clinical-stage pharmaceutical company, today reported financial results for the three months ended March 31, 2012. 

(Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO)

The Company reported a net loss for the first quarter of approximately ($2.5 million), or ($0.23) per share, compared with a net loss of ($2.6 million), or ($0.25) per share, for the same period last year.  The Company did not report any revenues for the first quarter 2012.  As of March 31, 2012, the Company had cash and cash equivalents of approximately $11.3 million. 

Sara B. Capitelli, Vice President, Finance and Principal Accounting Officer, commented, "Our financial resources were dedicated primarily to the clinical development of our primary drug candidate, ENMD-2076.  R&D expenses for the first quarter decreased from the previous year as fewer patients were enrolled in and remained on clinical trials during 2012, compared to the 2011 period when we were continuing to enroll patients in the ENMD-2076 Phase 2 ovarian cancer study.  We will continue to deploy our capital strategically to advance ENMD-2076, while at the same time continue to carefully monitor and control expenses.  We expect that R&D expenses for ENMD-2076 will remain consistent or increase from the first quarter as we execute on our drug development strategy in 2012."

Dr. Ken Ren, Chief Executive Officer, commented, "We start this next quarter with renewed determination, energy and a stronger balance sheet.  We expect to focus and execute on our development plans and leverage our resources in both the U.S. and China for drug development and financing." 

About EntreMedEntreMed, Inc. is a clinical-stage
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
2. EntreMed Raises $20 Million to Support Clinical Development Program
3. EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198
4. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
5. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
6. EntreMed to Present at The New York Society of Security Analysts Industry Conference
7. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
8. EntreMed Commences Continuous Dosing Clinical Trial For MKC-1
9. EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program
10. EntreMed to Highlight ENMD-2076 Kinase Inhibitor at 2008 AACR Annual Meeting
11. EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014 /PRNewswire-iReach/ -- Delivery of ... order is placed. Photo - ... professional and in-depth market survey on Global and ... the basic information of Hemodialysis Machine including its ... explores global and China,s top manufacturers of Hemodialysis ...
(Date:7/24/2014)... July 24, 2014   Royal Philips (NYSE: ... it has received 510(k) clearance from the U.S. Food ... ultrasound system, VISIQ, in the U.S. VISIQ ... benefits of greater mobility, performance and simplicity into a ... diagnostic scans for more OB patients. This ...
(Date:7/24/2014)... 24, 2014  Bruin Biometrics (BBI), a pioneer ... after two weeks of clinical briefings to over ... it gained substantial concurrence on both the clinical ... utility of BBI,s SEM Scanner. ... the respondents drawn from the European Wound Management ...
Breaking Medicine Technology:Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 2Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 3Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 4Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 5Philips receives FDA 510(k) clearance for its innovative ultra mobile VISIQ ultrasound system 2Philips receives FDA 510(k) clearance for its innovative ultra mobile VISIQ ultrasound system 3Bruin Biometrics Secures Support of EU Scientific Community for its SEM Scanner Technology 2
... Colo., April 26, 2012 /PRNewswire-iReach/ -- ... solutions, announces the availability of the Vending Fridge. ... lets consumers use a simple QR code scanner ... App to seamlessly purchase refrigerated products. The Vending ...
... April 26, 2012  IDenta Corp. (OTC: IDTA) CEO Yaacov Shoham ... released to OTC Markets the following files and asked them ... OTC Disclosure & News Service section." 1. Annual ... 2. Initial Company Information and Disclosure Statement ...
Cached Medicine Technology:ShelfX Releases A Fridge That Knows What You Took 2International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets. 2
(Date:7/24/2014)... (Boston)--Minority women who received the Human Papillomavirus Vaccination ... rates of abnormal Pap test results than those ... the journal Sexually Transmitted Diseases . ... Health and School of Medicine conducted a cross-sectional ... undergoing routine cervical cytology testing. HPV status and ...
(Date:7/24/2014)... On October 24-25th, 2014, hundreds of women ... Embassy Suites LAX North for DiabetesSisters’ power-packed weekend conference. This ... first time it has convened Los Angeles, CA area. It ... open the entire event to both women with diabetes and ... kind worldwide for women with diabetes, the event offers opportunities ...
(Date:7/24/2014)... low-income families vouchers to buy fruits and vegetables at ... foods, according to a new study. Low-income families ... to not having adequate access to healthy foods, cost ... address both of these obstacles, the researchers noted. ... may be able to bring a low-income person onto ...
(Date:7/24/2014)... babies are at risk for autism because they have an ... ways to detect Autism Spectrum Disorder (ASD) earlier in life, ... and how they relate to the possibility and severity of ... the connection between early joint attention before one year and ... communication that develops toward the end of the first year. ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 ACRIA & AMIDA ... BROOKS, , Save the Dates: August 7th ... are excited to cohost “A Dialogue for Life” forums this ... the White House Office of National AIDS Policy (ONAP). This ... efforts being made locally by AIDS organizations, consumers and advocates ...
Breaking Medicine News(10 mins):Health News:DiabetesSisters Brings Conference for Women with Diabetes Los Angeles for the First Time 2Health News:DiabetesSisters Brings Conference for Women with Diabetes Los Angeles for the First Time 3Health News:Farmers' Market Vouchers May Help Poorer Families Eat Healthier 2Health News:Early warning sign for babies at risk of autism 2Health News:White House Office of National AIDS Policy Hosts Public Forums in NYC Aug. 7 and 8, Sponsored by Amida Care and ACRIA 2Health News:White House Office of National AIDS Policy Hosts Public Forums in NYC Aug. 7 and 8, Sponsored by Amida Care and ACRIA 3
... IBS 2 times more likely in people with depression , , ... link between allergies and irritable bowel syndrome (IBS) in adults, ... in Chicago. , IBS occurs in about 15 percent of ... may lead to IBS symptoms in some patients, but the ...
... that run off the land and mix in rivers and ... on the salmon nervous system. These pesticides are widely used ... the food supply for humans may also pose an unexpected ... on how to assess the health effects of single chemicals ...
... Cory Watson Crowder &,DeGaris, P.C. (http://www.cwcd.com ), ... plaintiffs throughout the United States, who allegedly suffered,permanent ... drug used to prevent excessive bleeding during coronary,artery ... commonly bypass).,According to CBS News, 60 Minutes will ...
... to fight off a common sexually transmitted disease and increase ... to a new study. No such association is seen, however, ... loss, and the bodys response to the infection. , Human ... common subtype of the virus is HPV16. Infection with HPV16 ...
... 2 strains found, health officials still recommend inoculation , , ... now exists in virtually every state, and many of ... covered by this year,s influenza vaccine, U.S. health officials ... influenza activity in the early part of the season, ...
... New Report to be Released at Press Conference, ... CHICAGO, Feb. 15 U.S. Senator Dick Durbin,(D-IL) ... at the Chicago Children,s Museum on February 20 to ... advantage of the lack of,government regulation and have unleashed ...
Cached Medicine News:Health News:Allergy Disorders Linked With Irritable Bowel Syndrome 2Health News:60 Minutes to Report on Dangers of Trasylol: Cory Watson Crowder & DeGaris Involved in Litigation Against Pharmaceutical Giant Bayer AG 2Health News:Stress may increase a woman's risk of developing cervical cancer 2Health News:Flu Widespread in U.S., but Vaccine Is Poor Match 2Health News:Sen. Durbin & Public Health Leaders Call for Legislation to Protect Kids from Tobacco 2
CRP Liquid Conrtols level 2...
The AMY method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of amylase activity in serum, plasma and urine....
The GLU method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of glucose in serum, plasma, urine and cerebrospinal fluid....
Enzymatic Clearance assay for the in vitro quantitative determination of LDL-cholesterol in human serum and plasma....
Medicine Products: